Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits

Hyperlipidemia is a key risk factor for cardiovascular disease, and it is associated with lipid metabolic disorders and gut microbiota dysbiosis. Here, we aimed to investigate the beneficial effects of 3-month intake of a mixed probiotic formulation in hyperlipidemic patients (n = 27 and 29 in place...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Ma, Cuicui, Li, Yan, Zhang, Lei, A, lima, Yang, Chengcong, Zhao, Feiyan, Han, Haifeng, Shang, Dongyang, Yang, Fan, Zhang, Yuying, Zhang, Heping, Sun, Zhihong, Guo, Ruifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269629/
https://www.ncbi.nlm.nih.gov/pubmed/37022264
http://dx.doi.org/10.1128/spectrum.04440-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269629/
https://www.ncbi.nlm.nih.gov/pubmed/37022264
http://dx.doi.org/10.1128/spectrum.04440-22

Ejemplares similares